1. Mycobacterium vaccae Reduces Scratching Behavior but not the Rash in NC Mice with Eczema: A Randomized, Blinded, Placebo-Controlled Trial 
Peter D. Arkwright, Chie Fujisawa, Akane Tanaka, Hiroshi Matsuda 
Journal of Investigative Dermatology 
Volume 124, Issue 1, Pages (January 2005)
DOI: /j X x
Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

2. Figure 1
Scatterplot showing the correlation between clinical eczema score and scratch frequency during an 18-min observation period in NC/Nga mice. Simultaneous measurements of the two scores were made on individual mice between 8 and 26 wk of age. N=120 measurements. Calculated linear regression line is shown.
Journal of Investigative Dermatology  , DOI: ( /j X x)
Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

3. Figure 2
Comparative effects of placebo, SRP299 (0.01 mg dose), and SRP299 (0.1 mg dose) on the age of onset (weeks) of eczema (clinical eczema scores >2) in NC/Nga mice. Bars represent median value.
Journal of Investigative Dermatology  , DOI: ( /j X x)
Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

4. Figure 3
Comparative effects of placebo, SRP299 (0.01 mg dose), and SRP299 (0.1 mg dose) on the peak severity of eczema in NC/Nga mice. (A) Peak clinical eczema score, (B) peak scratch frequency. Bars represent median value. *p<0.05 (Kruskal–Wallis H test).
Journal of Investigative Dermatology  , DOI: ( /j X x)
Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions